Towards mitochondria-specific delivery of apoptosis-inducing agents: DQAsomal incorporated paclitaxelCHENG, S. M; PABBA, S; TORCHILIN, V. P et al.STP pharma sciences. 2005, Vol 15, Num 1, pp 81-86, issn 1157-1489, 6 p.Article

Design and in vitro-in vivo evaluation of a bi-layered tablet containing benzocaine for local buccal administrationMAFFEI, P; LOMBARDI BORGIA, S; SFORZINI, A et al.STP pharma sciences. 2004, Vol 14, Num 5, pp 363-372, issn 1157-1489, 10 p.Article

Original tamoxifen-loaded gels containing cyclodextrins: in situ self-assembling systems for cancer treatmentDAOUD-MAHAMMED, S; COUVREUR, P; AMIEL, C et al.STP pharma sciences. 2004, Vol 14, Num 1, pp 51-55, issn 1157-1489, 5 p.Article

Polymer-enzyme inhibitor conjugates: influence of the molecular mass on the inhibition of membrane-bound aminopeptidase N activityLEITNER, V. M; BERNKOP-SCHNÜRCH, A.STP pharma sciences. 2004, Vol 14, Num 6, pp 495-498, issn 1157-1489, 4 p.Article

Properties of solid dispersion of piroxicam in Pluronic F-98EL-BADRY, M; FATHY, M.STP pharma sciences. 2004, Vol 14, Num 3, pp 199-205, issn 1157-1489, 7 p.Article

Transdermal iontophoresis of timolol across human stratum corneum: effect of temperature and vehicle formulationFATOUROS, D. G; BOUWSTRA, J. A.STP pharma sciences. 2004, Vol 14, Num 6, pp 479-484, issn 1157-1489, 6 p.Article

Use of experimental design for identifying the most important formulation and technological variables in pelletization by powder layeringTOMUTA, I; LEUCUTA, S. E.STP pharma sciences. 2004, Vol 14, Num 3, pp 215-221, issn 1157-1489, 7 p.Article

Delivery of diclofenac sodium via non-disintegrating bioadhesive tablets of paraffin waxATTAMA, A. A; ADIKWU, M. U; NNAMANI, P. O et al.STP pharma sciences. 2003, Vol 13, Num 2, pp 147-150, issn 1157-1489, 4 p.Article

Development of films and matrices based on chitosan and polyacrylic acid for vaginal delivery of acyclovirROSSI, S; SANDRI, G; FERRARI, F et al.STP pharma sciences. 2003, Vol 13, Num 3, pp 183-190, issn 1157-1489, 8 p.Article

Efficacy of nanoparticles containing irinotecan prepared using poly(DL-lactic acid) and poly(ethylene glycol)-poly(propylene glycol)-poly(ethylene glycol) against M5076 tumor in the early liver metastatic stageMACHIDA, Y; ONISHI, H; KATO, Y et al.STP pharma sciences. 2003, Vol 13, Num 4, pp 225-230, issn 1157-1489, 6 p.Article

In vitro cellular toxicity and in vivo lethality studies of alkylated α-anhydro cyclodextrinsDEBOUZY, J. C; GADELLE, A; PAILLER, J. Y et al.STP pharma sciences. 2003, Vol 13, Num 3, pp 209-214, issn 1157-1489, 6 p.Article

Supercritical fluids applications in the pharmaceutical industryPERRUT, M.STP pharma sciences. 2003, Vol 13, Num 2, pp 83-91, issn 1157-1489, 9 p.Article

Design and characterization of an oral delivery system for insulin administrationSANTIAGO, R. M; FIALHO, S. L; SILVA-CUNHA, A et al.STP pharma sciences. 2003, Vol 13, Num 6, pp 377-380, issn 1157-1489, 4 p.Article

Drug permeation through a swollen cross-linked amylose starch membraneRAHMOUNI, M; LENAERTS, V; LEROUX, J.-C et al.STP pharma sciences. 2003, Vol 13, Num 5, pp 341-348, issn 1157-1489, 8 p.Article

Preparation of nanoparticles by the nanoprecipitation of low molecular weight poly(I)lactidePELTONEN, L; KOISTINEN, P; HIRVONEN, J et al.STP pharma sciences. 2003, Vol 13, Num 5, pp 299-304, issn 1157-1489, 6 p.Article

Lectin-mediated drug delivery: fundamentals and perspectivesGABOR, F; WIRTH, M.STP pharma sciences. 2003, Vol 13, Num 1, pp 3-16, issn 1157-1489, 14 p.Article

Microencapsulated lipid cores for site-specific delivery of corticosteroid and peptide drugs to the colonic regionTORRES, D; RODRIGUEZ, M; CUNA, M et al.STP pharma sciences. 2003, Vol 13, Num 1, pp 49-56, issn 1157-1489, 8 p.Article

Polyacrylate-based microparticles for sustained release of metoclopramideGANZA-GONZALEZ, A; ANGUIANO-IGEA, S; OTERO-ESPINAR, F. J et al.STP pharma sciences. 2002, Vol 12, Num 2, pp 103-107, issn 1157-1489Article

The application of ultrasonics in the assessment of the in vitro dissolution rate of powdersZEMA, L; SANGALLI, M. E; MARONI, A et al.STP pharma sciences. 2002, Vol 12, Num 3, pp 163-166, issn 1157-1489Article

Use of a 3³ factorial design and the desirability function for the characterization and optimization of a pelletization processKORAKIANITI, E. S; REKKAS, D. M; DALLAS, P. P et al.STP pharma sciences. 2002, Vol 12, Num 3, pp 191-197, issn 1157-1489Article

Controlled dissolution properties of indomethacin by compounding with silicaWATANABE, T; OHNO, I; WAKIYAMA, N et al.STP pharma sciences. 2002, Vol 12, Num 6, pp 363-367, issn 1157-1489, 5 p.Article

Gelatin microspheres containing epirubicin: pharmaceutical, pharmacokinetic and antitumour effect characterizationACHIM, M; RISCA, R; DAICOVICIU, D et al.STP pharma sciences. 2002, Vol 12, Num 5, pp 275-282, issn 1157-1489, 8 p.Article

Modulation of gene expression as therapy for atherosclerosisBIESSEN, E. A. L; VON DER THÜSEN, J. H; VAN ROSSENBERG, S. M. W et al.STP pharma sciences. 2002, Vol 12, Num 4, pp 223-227, issn 1157-1489, 5 p.Article

Physical characteristics of o/w emulsions based on acrylate polymeric emulsifiers or combination polymeric emulsifier/non-ionic emulsifierSAVIC, S; MILIC, J; VULETA, G et al.STP pharma sciences. 2002, Vol 12, Num 5, pp 321-327, issn 1157-1489, 7 p.Article

Preparation and stability of a chamomile ointment containing a supercritical carbon dioxide chamomile extract/β-cyclodextrin inclusion complexWALECZEK, K. J; HEMPEL, B; SCHMIDT, P. C et al.STP pharma sciences. 2002, Vol 12, Num 5, pp 329-333, issn 1157-1489, 5 p.Article